QbDVision Names Christoph Pistek Vice President
The digital CMC platform provider appointed Pistek, formerly of Takeda, to lead its Digital CMC Solutions work.
Updated on Nov. 14, 2026 in People

QbDVision, a provider of a digital CMC platform for pharmaceutical and biotechnology companies, appointed Christoph Pistek as vice president, Digital CMC Solutions. Pistek joins from Takeda, where he was vice president and head of sustainability and technology in pharmaceutical sciences.
Why it matters
The appointment brings a leader with more than 20 years of experience across R&D, technical operations and digital transformation into a role focused on replacing manual, paper-based workflows with structured data and automation. QbDVision said Pistek will help customers move from initial business objectives through to technology implementation.
Pistek brings more than 20 years of experience in R&D, technical operations and digital transformation to the role. He previously implemented Digital CMC Solutions at scale within a global pharmaceutical company.
The players
QbDVision
QbDVision is a provider of a digital CMC platform for pharmaceutical and biotechnology companies, and a founding member of the Digital CMC Consortium.
Takeda
Takeda is a global pharmaceutical company headquartered in Japan that develops and markets medicines across several therapeutic areas.
The details
Pistek joined QbDVision from Takeda and will guide customers from initial business objectives through technology implementation. QbDVision's platform connects product and process knowledge in one structured system, and the company is a founding member of the Digital CMC Consortium.
Timeline
Nov. 14, 2026: QbDVision announced Pistek's appointment as vice president, Digital CMC Solutions.
Digital Transformation Push
The appointment reflects the push to replace paper-based CMC workflows with structured digital systems across pharmaceutical development. Digital CMC Solutions, which QbDVision supports through its membership in the Digital CMC Consortium, are positioned to extend into areas that have historically received less investment.
For pharmaceutical and biotech teams in the United States, the appointment signals continued vendor investment in structured digital CMC tools. Companies evaluating digital workflow platforms may see more implementation support offered alongside software.
The takeaway
Pharmaceutical teams weighing digital CMC tools should look closely at implementation support alongside the software itself. Leadership hires focused on moving customers from strategy to deployment often signal where a vendor is investing.
Further reading
Explore more People coverage for other leadership moves in the business world.
Source note: This article includes information reported by Pharmabiz.






